Company/Partner | Drug Name | Launch Date |
Amgen | Amjevita* | January 2023 |
Samsung Bioepis/Merck | SB5 | June 2023 |
Mylan/Fujifilm Kyowa Kirin Biologics | Hulio | August 2023 |
Fresenius Kabi | MSB11022 | September 2023 |
Sandoz | Hyrimoz* | September 2023 |
Pfizer | PF-06410293 | November 2023 |
Momenta | M923 | December 2023 |
Coherus | CHS-1720 | December 2023 |
*Received FDA Approval. |